España
Acceder
  1. Inicio
  2. Perfil de jmsl2015
  3. Contenidos recomendados por jmsl2015

Contenidos recomendados por jmsl2015

jmsl2015 28/01/21 22:57
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Menuda alegría y enhorabuena a todos. Felicitaciones , y como Framus es la primera vez que estoy fuera del valor desde 2015. Pero mi alegría es enorme !!!! 
Ir a respuesta
jmsl2015 22/01/21 23:01
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Novavax Names Madelyn Caltabiano Senior Vice President, Global Program Managementhttps://ir.novavax.com/news-releases/news-release-details/novavax-names-madelyn-caltabiano-senior-vice-president-globalGAITHERSBURG, Md., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Madelyn ‘Lyn’ Caltabiano, Ph.D. to the position of Senior Vice President, Global Program Management. In this newly created role, Dr. Caltabiano will lead and expand the Global Program Management organization for the company’s pipeline and will develop appropriate strategies to assess the company’s operational performance, including areas related to portfolio valuation, milestone decision making and prioritization. She will report directly to Stanley C. Erck, President and Chief Executive Officer.“Lyn’s deep experience in managing complex global programs will be critical as we work to simultaneously advance NVX-CoV2373 regulatory activities forward in multiple regions,” said Mr. Erck. “We welcome her invaluable project management experience as Novavax works to effectively deliver our vaccine candidate in the fight against the COVID-19 pandemic.”Dr. Caltabiano joins Novavax from NexEos Diagnostics, Inc., where she was Development Lead and a core member of the management team. Previously, as Senior Vice President, Global Project and Alliance Management at Merck Research Laboratories, she rebuilt the R&D project and Alliance Management organizations and led the development of critical portfolio management and executive decision-making processes. Earlier, Dr. Caltabiano spent more than a decade at GlaxoSmithKline where she built the Alliance Management organization, headed project operations in Oncology R&D, and led the development of several new therapeutics.Dr. Caltabiano graduated summa cum laude from Drexel University with a Bachelor of Science in biological sciences and earned a doctorate in pathology from the University of Pennsylvania.
Ir a respuesta
jmsl2015 21/01/21 22:16
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
Tampoco me gusta el falso breakout del canal, ni la presión de la oferta de las velas en torno a los 130$. Compra en parte baja del canal y stop ajustado. :)CANAL TF 5 MIN
Ir a respuesta
jmsl2015 20/01/21 08:37
Ha respondido al tema Novavax (NVAX): Un Nuevo Comienzo
South Korea may secure additional COVID-19 vaccines from Novavax, Moon says | Article [AMP] | Reuters **60M instead of originally 20M doses according to this article from my favorite #covidcaccine developer.**https://t.co/c5X5s75CqH?amp=1
Ir a respuesta